IL39990A - Pharmaceutical preparation containing 1,3-bis dinatran salt (2-carboxychromone-5-ileoxy) -Propane-2-ol - Google Patents

Pharmaceutical preparation containing 1,3-bis dinatran salt (2-carboxychromone-5-ileoxy) -Propane-2-ol

Info

Publication number
IL39990A
IL39990A IL39990A IL3999072A IL39990A IL 39990 A IL39990 A IL 39990A IL 39990 A IL39990 A IL 39990A IL 3999072 A IL3999072 A IL 3999072A IL 39990 A IL39990 A IL 39990A
Authority
IL
Israel
Prior art keywords
composition according
carrier
microns
range
particle size
Prior art date
Application number
IL39990A
Other languages
English (en)
Hebrew (he)
Other versions
IL39990A0 (en
Original Assignee
Fisons Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=36763080&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=IL39990(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Fisons Ltd filed Critical Fisons Ltd
Publication of IL39990A0 publication Critical patent/IL39990A0/xx
Publication of IL39990A publication Critical patent/IL39990A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/0075—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a dry powder inhaler [DPI], e.g. comprising micronized drug mixed with lactose carrier particles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Pulmonology (AREA)
  • Otolaryngology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pyrane Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
IL39990A 1971-08-10 1972-07-25 Pharmaceutical preparation containing 1,3-bis dinatran salt (2-carboxychromone-5-ileoxy) -Propane-2-ol IL39990A (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
GB3745671A GB1410588A (en) 1971-08-10 1971-08-10 Composition
DK392872A DK131891C (da) 1971-08-10 1972-08-09 Fremgangsmade til fremstilling af et pulverpreparat til inhalation
ZA730284A ZA73284B (en) 1971-08-10 1973-01-15 Pharmaceutical powder composition containing sodium cromoglycate
AU51191/73A AU5119173A (en) 1971-08-10 1973-01-17 Composition
ES410910A ES410910A1 (es) 1971-08-10 1973-01-24 Un procedimiento para la preparacion de una composicion farmaceutica en polvo para inhalacion.

Publications (2)

Publication Number Publication Date
IL39990A0 IL39990A0 (en) 1972-09-28
IL39990A true IL39990A (en) 1977-02-28

Family

ID=36763080

Family Applications (1)

Application Number Title Priority Date Filing Date
IL39990A IL39990A (en) 1971-08-10 1972-07-25 Pharmaceutical preparation containing 1,3-bis dinatran salt (2-carboxychromone-5-ileoxy) -Propane-2-ol

Country Status (19)

Country Link
US (1) US4009280A (fr)
JP (1) JPS5652001B2 (fr)
AT (1) AT333974B (fr)
AU (1) AU5119173A (fr)
CA (1) CA992461A (fr)
DE (1) DE2239091A1 (fr)
DK (2) DK131891C (fr)
ES (1) ES410910A1 (fr)
FI (1) FI56487C (fr)
FR (1) FR2150759B1 (fr)
GB (1) GB1410588A (fr)
IE (1) IE37102B1 (fr)
IL (1) IL39990A (fr)
LU (1) LU66875A1 (fr)
NL (1) NL7210780A (fr)
NO (1) NO140747C (fr)
SE (1) SE411842B (fr)
ZA (1) ZA73284B (fr)
ZM (1) ZM11971A1 (fr)

Families Citing this family (42)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5042827A (fr) * 1973-08-20 1975-04-18
JPS5042826A (fr) * 1973-08-20 1975-04-18
JPS5042819A (fr) * 1973-08-20 1975-04-18
JPS6019043B2 (ja) * 1975-12-11 1985-05-14 ソニー株式会社 磁気再生装置
JPS5313111U (fr) * 1976-07-16 1978-02-03
US4238502A (en) * 1978-08-03 1980-12-09 Fisons Limited Method of treating psychiatric conditions
BE891013A (fr) * 1980-11-05 1982-05-05 Fisons Ltd Compositions pharmaceutique
DE3636209A1 (de) * 1986-10-24 1988-04-28 Lentia Gmbh Verfahren zur herstellung eines bindemittelfreien tablettierfaehigen celiprololhydrochlorid-granulates
DE4140689B4 (de) * 1991-12-10 2007-11-22 Boehringer Ingelheim Kg Inhalationspulver und Verfahren zu ihrer Herstellung
GB9322014D0 (en) 1993-10-26 1993-12-15 Co Ordinated Drug Dev Improvements in and relating to carrier particles for use in dry powder inhalers
GB9404945D0 (en) 1994-03-15 1994-04-27 Glaxo Group Ltd Pharmaceutical composition
DE4425255A1 (de) * 1994-07-16 1996-01-18 Asta Medica Ag Formulierung zur inhalativen Applikation
GB9501841D0 (en) * 1995-01-31 1995-03-22 Co Ordinated Drug Dev Improvements in and relating to carrier particles for use in dry powder inhalers
US5747002A (en) * 1995-04-05 1998-05-05 Genentech, Inc. Preparation of sodium chloride aerosol formulations
US20020052310A1 (en) * 1997-09-15 2002-05-02 Massachusetts Institute Of Technology The Penn State Research Foundation Particles for inhalation having sustained release properties
US5985309A (en) * 1996-05-24 1999-11-16 Massachusetts Institute Of Technology Preparation of particles for inhalation
US5874064A (en) * 1996-05-24 1999-02-23 Massachusetts Institute Of Technology Aerodynamically light particles for pulmonary drug delivery
US6652837B1 (en) 1996-05-24 2003-11-25 Massachusetts Institute Of Technology Preparation of novel particles for inhalation
US7052678B2 (en) 1997-09-15 2006-05-30 Massachusetts Institute Of Technology Particles for inhalation having sustained release properties
US6565885B1 (en) * 1997-09-29 2003-05-20 Inhale Therapeutic Systems, Inc. Methods of spray drying pharmaceutical compositions
US20060165606A1 (en) * 1997-09-29 2006-07-27 Nektar Therapeutics Pulmonary delivery particles comprising water insoluble or crystalline active agents
US6309623B1 (en) * 1997-09-29 2001-10-30 Inhale Therapeutic Systems, Inc. Stabilized preparations for use in metered dose inhalers
EP1019020A1 (fr) † 1997-09-29 2000-07-19 Inhale Therapeutic Systems, Inc. Preparations bioactives stabilisees et leur procedes d'utilisation
US6956021B1 (en) * 1998-08-25 2005-10-18 Advanced Inhalation Research, Inc. Stable spray-dried protein formulations
CA2382821A1 (fr) * 1999-08-25 2001-03-01 Advanced Inhalation Research, Inc. Modulation de liberation a partir de formulations seches en poudre
US20010036481A1 (en) * 1999-08-25 2001-11-01 Advanced Inhalation Research, Inc. Modulation of release from dry powder formulations
US6749835B1 (en) 1999-08-25 2004-06-15 Advanced Inhalation Research, Inc. Formulation for spray-drying large porous particles
US7678364B2 (en) 1999-08-25 2010-03-16 Alkermes, Inc. Particles for inhalation having sustained release properties
US8404217B2 (en) * 2000-05-10 2013-03-26 Novartis Ag Formulation for pulmonary administration of antifungal agents, and associated methods of manufacture and use
US7871598B1 (en) 2000-05-10 2011-01-18 Novartis Ag Stable metal ion-lipid powdered pharmaceutical compositions for drug delivery and methods of use
US7442388B2 (en) 2000-05-10 2008-10-28 Weers Jeffry G Phospholipid-based powders for drug delivery
US20020106368A1 (en) * 2000-07-28 2002-08-08 Adrian Bot Novel methods and compositions to upregulate, redirect or limit immune responses to peptides, proteins and other bioactive compounds and vectors expressing the same
US20020141946A1 (en) * 2000-12-29 2002-10-03 Advanced Inhalation Research, Inc. Particles for inhalation having rapid release properties
CA2433335C (fr) 2000-12-29 2010-04-20 Advanced Inhalation Research, Inc. Particules a liberation prolongee destinees a etre inhalees
EP1359902B1 (fr) * 2001-02-06 2007-08-08 Innovata Biomed Limited Composition bimodale de poudre seche pour l'inhalation
US7182961B2 (en) * 2001-11-20 2007-02-27 Advanced Inhalation Research, Inc. Particulate compositions for pulmonary delivery
WO2003043603A1 (fr) * 2001-11-20 2003-05-30 Advanced Inhalation Research, Inc. Compositions particulaires destinees a augmenter la solubilite d'agents faiblement solubles
CA2468958C (fr) * 2001-12-19 2012-07-03 Nektar Therapeutics Administration pulmonaire d'aminoglycosides
US6889690B2 (en) * 2002-05-10 2005-05-10 Oriel Therapeutics, Inc. Dry powder inhalers, related blister devices, and associated methods of dispensing dry powder substances and fabricating blister packages
US7763280B2 (en) * 2002-11-28 2010-07-27 Boehringer Ingelheim Pharma Gmbh & Co. Kg Tiotropium containing powder formulation for inhalation
US20070031342A1 (en) * 2005-06-22 2007-02-08 Nektar Therapeutics Sustained release microparticles for pulmonary delivery
KR101657029B1 (ko) * 2008-07-24 2016-09-12 레르 리키드 쏘시에떼 아노님 뿌르 레드 에렉스뿔라따시옹 데 프로세데 조르즈 클로드 전이 금속 함유 필름의 침착을 위한 헤테로렙틱 시클로펜타디에닐 전이 금속 전구체

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3121096A (en) * 1961-12-27 1964-02-11 Roussel Uclaf New process of preparation of 3-methyl chromone
GB1144905A (en) * 1965-03-25 1969-03-12 Fisons Pharmaceuticals Ltd Substituted bis-(2-carboxy-chromonyl-oxy) derivatives and preparation and pharmaceutical compositions thereof
US3686412A (en) * 1965-03-25 1972-08-22 Colin Fitzmaurice Compositions containing bis-chromonyl compounds for inhibiting antigen-antibody reactions
GB1147976A (en) * 1965-12-21 1969-04-10 Fisons Pharmaceuticals Ltd Chromone derivatives
GB1190193A (en) * 1966-07-05 1970-04-29 Fisons Pharmaceuticals Ltd Bis-(2-Carboxy-Chromonyl-Oxy) Derivatives, their preparation, and Pharmaceutical Compositions thereof
GB1242211A (en) * 1967-08-08 1971-08-11 Fisons Pharmaceuticals Ltd Pharmaceutical composition
GB1223690A (en) * 1967-10-17 1971-03-03 Fisons Pharmaceuticals Ltd Substituted chromon-2-carboxylic acids
GB1292601A (en) * 1968-10-30 1972-10-11 Fisons Pharmaceuticals Ltd Bis-(2-carboxy-chromone) compounds, their preparation and pharmaceutical compositions containing them

Also Published As

Publication number Publication date
IE37102B1 (en) 1977-05-11
ES410910A1 (es) 1976-07-16
FI56487B (fi) 1979-10-31
AU5119173A (en) 1974-07-18
NO140747C (no) 1979-11-07
NL7210780A (fr) 1973-02-13
FI56487C (fi) 1980-02-11
ZA73284B (en) 1973-11-28
DK131891B (da) 1975-09-22
DK146974B (da) 1984-03-05
DK535774A (fr) 1975-06-02
IL39990A0 (en) 1972-09-28
FR2150759A1 (fr) 1973-04-13
FR2150759B1 (fr) 1975-10-31
JPS4826764A (fr) 1973-04-09
NO140747B (no) 1979-07-30
US4009280A (en) 1977-02-22
LU66875A1 (fr) 1973-03-23
GB1410588A (en) 1975-10-22
DK146974C (da) 1984-08-13
SE411842B (sv) 1980-02-11
ATA39073A (de) 1976-04-15
DK131891C (da) 1976-02-23
JPS5652001B2 (fr) 1981-12-09
DE2239091A1 (de) 1973-02-22
ZM11971A1 (en) 1973-02-21
AT333974B (de) 1976-12-27
CA992461A (en) 1976-07-06

Similar Documents

Publication Publication Date Title
US4009280A (en) Powder composition for inhalation therapy
US3957965A (en) Sodium chromoglycate inhalation medicament
US3634582A (en) Pharmaceutical compositions
EP0072046B1 (fr) Médicaments pour inhalation, méthodes pour leur production et formulations pharmaceutiques les contenant
US4199578A (en) Composition
US6199607B1 (en) Formulation for inhalation
AU635616B2 (en) Aerosol carriers
CA2353448C (fr) Ameliorations apportees a des poudres
JP3567329B2 (ja) 吸入散剤及びその製造方法
GB2105189A (en) Inhalation drugs
EP1232745A1 (fr) Particules porteuses utilisées dans des inhalateurs à poudre sèche
EP1009394B1 (fr) Nouvelle formulation pour inhalation ayant une masse volumique de 0,28 a 0,38 g/ml et contenant du formoterol
RU2180563C2 (ru) Препарат для ингаляции, имеющий насыпную объемную плотность от 0,28 до 0,38 г/мл, содержащий будесонид
KR20010032303A (ko) 연질 펠렛상 약제 및 그 제조방법
US3860618A (en) Chromone
AU728768B2 (en) New formulation for inhalation having a poured bulk density of from 0.28 to 0.38 g/ml, comprising terbutaline sulphate, a process for preparing the formulation and the use thereof
US5980949A (en) Formulation for inhalation
AU2003226842B2 (en) A method for treating carrier particles and its use
IE66154B1 (en) Pharmaceutical Composition
US5198221A (en) Pharmaceutical composition
PT91548B (pt) Processo para a preparacao de novas composicoes farmaceuticas contendo nedocromil calcico